INDmoney
Beam Therapeutics Inc Forecast and Target Price
$31.25
Beam Therapeutics Inc (BEAM) Share Price Forecast
Currently 21 wall-street analysts regularly analyze the financials of Beam Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 21 analysts offering 12-month price forecasts for Beam Therapeutics Inc (BEAM) have a share price target of $45.2. This median of share price forecast represents a 44.64% upside from the latest price of $31.25 as on 21.01.26.
Beam Therapeutics Inc (BEAM) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Beam Therapeutics Inc (BEAM) share price will touch around $45.2 in next 12-months.
Beam Therapeutics Inc (BEAM) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Beam Therapeutics Inc's share price and its median forecast price. As on 21.01.26, the difference is -47.64%
Beam Therapeutics Inc (BEAM): Difference between Current Price & Median Forecasted Price
Beam Therapeutics Inc (BEAM) Share Price : Analyst Recommendation
Based on 21 analysts tracking and researching Beam Therapeutics Inc (BEAM) share have hold recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 6 | 6 | 6 |
| Outperform | 7 | 7 | 7 |
| Hold | 8 | 8 | 8 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |